CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 195 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $207,000 | -21.3% | 8,375 | -6.4% | 0.00% | -50.0% |
| Q3 2018 | $263,000 | -46.9% | 8,945 | -18.5% | 0.00% | -50.0% |
| Q2 2018 | $495,000 | +121.0% | 10,970 | +38.9% | 0.00% | +100.0% |
| Q1 2018 | $224,000 | +12.0% | 7,897 | +119.9% | 0.00% | 0.0% |
| Q3 2017 | $200,000 | -47.1% | 3,591 | -27.1% | 0.00% | -33.3% |
| Q2 2017 | $378,000 | -36.8% | 4,929 | -70.4% | 0.00% | -57.1% |
| Q3 2016 | $598,000 | +200.5% | 16,625 | +59.5% | 0.01% | +600.0% |
| Q1 2016 | $199,000 | -31.8% | 10,425 | +25.6% | 0.00% | -66.7% |
| Q4 2015 | $292,000 | -29.6% | 8,300 | +84.2% | 0.00% | -40.0% |
| Q3 2015 | $415,000 | +38.3% | 4,507 | +32.3% | 0.01% | 0.0% |
| Q2 2015 | $300,000 | – | 3,407 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |